FDA Approves Talicia To Treat Superbug Linked To Stomach Cancer

Health officials are increasingly concerned about the rise of antibiotic-resistant infections, also known as ‘superbugs’. However, this month an Israel-based pharmaceutical company showed that we may be able to combat this threat. The FDA approved Talicia to treat the increasing drug resistance Helicobacter pylori, news which suggests that the superbug apocalypse may not be as grim as we thought.